UM1 HL113460/HL/NHLBI NIH HHS/United States[Grant Number] - Search Results

Year	Number of Results
2011	1
2012	5
2013	5
2014	9
2015	18
2016	17
2017	15
2018	16
2019	6
2020	2
2021	4
2022	7
2023	2
2024	0

1

Efficacy of a growth hormone-releasing hormone agonist in a murine model of cardiometabolic heart failure with preserved ejection fraction.

Kanashiro-Takeuchi RM, Takeuchi LM, Dulce RA, Kazmierczak K, Balkan W, Cai R, Sha W, Schally AV, Hare JM. Kanashiro-Takeuchi RM, et al. Am J Physiol Heart Circ Physiol. 2023 Jun 1;324(6):H739-H750. doi: 10.1152/ajpheart.00601.2022. Epub 2023 Mar 10. Am J Physiol Heart Circ Physiol. 2023. PMID: 36897749

2

Mouse Model of Heart Failure With Preserved Ejection Fraction Driven by Hyperlipidemia and Enhanced Cardiac Low-Density Lipoprotein Receptor Expression.

Williams M, Capcha JMC, Irion CI, Seo G, Lambert G, Kamiar A, Yousefi K, Kanashiro-Takeuchi R, Takeuchi L, Saad AG, Mendez A, Webster KA, Goldberger JJ, Hare JM, Shehadeh LA. Williams M, et al. J Am Heart Assoc. 2022 Sep 6;11(17):e027216. doi: 10.1161/JAHA.122.027216. Epub 2022 Sep 3. J Am Heart Assoc. 2022. PMID: 36056728 Free PMC article.

3

Synthetic growth hormone-releasing hormone agonist ameliorates the myocardial pathophysiology characteristic of heart failure with preserved ejection fraction.

Dulce RA, Kanashiro-Takeuchi RM, Takeuchi LM, Salerno AG, Wanschel ACBA, Kulandavelu S, Balkan W, Zuttion MSSR, Cai R, Schally AV, Hare JM. Dulce RA, et al. Cardiovasc Res. 2023 Feb 3;118(18):3586-3601. doi: 10.1093/cvr/cvac098. Cardiovasc Res. 2023. PMID: 35704032 Free PMC article.

4

Allogeneic Cell Combination Therapy Ameliorates Chronic Kidney Disease-Induced Heart Failure with Preserved Ejection Fraction.

Rieger AC, Tompkins BA, Natsumeda M, Florea V, Banerjee MN, Rodriguez J, Rosado M, Porras V, Valasaki K, Takeuchi LM, Collon K, Desai S, Bellio MA, Khan A, Kashikar ND, Landin AM, Hardin DV, Rodriguez DA, Balkan W, Hare JM, Schulman IH. Rieger AC, et al. Stem Cells Transl Med. 2022 Mar 3;11(1):59-72. doi: 10.1093/stcltm/szab004. Stem Cells Transl Med. 2022. PMID: 35641169 Free PMC article.

5

Utility of exercise testing to assess athletes for post COVID-19 myocarditis.

Mitrani RD, Alfadhli J, Lowery MH, Best TM, Hare JM, Fishman J, Dong C, Siegel Y, Scavo V, Basham GJ, Myerburg RJ, Goldberger JJ. Mitrani RD, et al. Am Heart J Plus. 2022 Feb;14:100125. doi: 10.1016/j.ahjo.2022.100125. Epub 2022 Mar 31. Am Heart J Plus. 2022. PMID: 35378797 Free PMC article.

6

Leptin secreted from testicular microenvironment modulates hedgehog signaling to augment the endogenous function of Leydig cells.

Arora H, Qureshi R, Khodamoradi K, Seetharam D, Parmar M, Van Booven DJ, Issa IC, Sackstein R, Lamb D, Hare JM, Ramasamy R. Arora H, et al. Cell Death Dis. 2022 Mar 4;13(3):208. doi: 10.1038/s41419-022-04658-3. Cell Death Dis. 2022. PMID: 35246515 Free PMC article.

7

S-Nitrosoglutathione Reductase Deficiency Causes Aberrant Placental S-Nitrosylation and Preeclampsia.

Kulandavelu S, Dulce RA, Murray CI, Bellio MA, Fritsch J, Kanashiro-Takeuchi R, Arora H, Paulino E, Soetkamp D, Balkan W, Van Eyk JE, Hare JM. Kulandavelu S, et al. J Am Heart Assoc. 2022 Mar;11(5):e024008. doi: 10.1161/JAHA.121.024008. Epub 2022 Feb 22. J Am Heart Assoc. 2022. PMID: 35191317 Free PMC article.

8

Systemic delivery of large-scale manufactured Wharton's Jelly mesenchymal stem cell-derived extracellular vesicles improves cardiac function after myocardial infarction.

Bellio MA, Kanashiro-Takeuchi RM, Takeuchi L, Kulandavelu S, Lee YS, Balkan W, Young KC, Hare JM, Khan A. Bellio MA, et al. J Cardiovasc Aging. 2022;2:9. doi: 10.20517/jca.2021.21. Epub 2022 Jan 5. J Cardiovasc Aging. 2022. PMID: 35112111 Free PMC article.

9

Mechanism of Action of Mesenchymal Stem Cells (MSCs): impact of delivery method.

Bagno LL, Salerno AG, Balkan W, Hare JM. Bagno LL, et al. Expert Opin Biol Ther. 2022 Apr;22(4):449-463. doi: 10.1080/14712598.2022.2016695. Epub 2021 Dec 27. Expert Opin Biol Ther. 2022. PMID: 34882517 Free PMC article.

10

S-nitrosoglutathione reductase (GSNOR) deficiency accelerates cardiomyocyte differentiation of induced pluripotent stem cells.

Salerno AG, Wanschel ACBA, Dulce RA, Hatzistergos KE, Balkan W, Hare JM. Salerno AG, et al. J Cardiovasc Aging. 2021;1:13. doi: 10.20517/jca.2021.19. Epub 2021 Sep 7. J Cardiovasc Aging. 2021. PMID: 34790975 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

93 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

93 results

Results by year